George Yancopoulos

George D. Yancopoulos (born 1959) is a Greek-American biomedical scientist who is the co-founder, president and chief scientific officer of Regeneron Pharmaceuticals.

Yancopoulos is an elected member of the National Academy of Sciences, a fellow of the American Academy of Arts and Sciences (AAAS), and the holder of more than 100 patents. He is a principal inventor and developer of Regeneron's ten FDA-approved or -authorized treatments, as well as of Regeneron's foundational technologies for target and drug development, such as its proprietary TRAP technology, and the VelociGene and VelocImmune antibody technologies. Provided by Wikipedia
Showing 1 - 2 results of 2 for search 'George D. Yancopoulos', query time: 0.01s Refine Results
  1. 1
    GDF8 and activin A blockade protects against GLP-1–induced muscle loss while enhancing fat loss in obese male mice and non-human primates

    GDF8 and activin A blockade protects against GLP-1–induced muscle loss while enhancing fat loss in obese male mice and non-human primates by Jason W. Mastaitis, Daniel Gomez, José G. Raya, Diana Li, Soo Min, Michael Stec, Sandra Kleiner, Toya McWilliams, Judith Y. Altarejos, Andrew J. Murphy, George D. Yancopoulos, Mark W. Sleeman

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    GDF8 and activin A are the key negative regulators of muscle mass in postmenopausal females: a randomized phase I trial

    GDF8 and activin A are the key negative regulators of muscle mass in postmenopausal females: a randomized phase I trial by Dinko Gonzalez Trotter, Stephen Donahue, Chris Wynne, Shazia Ali, Prodromos Parasoglou, Anita Boyapati, Kusha Mohammadi, Bret J. Musser, Pretty Meier, Jason Mastaitis, Mark W. Sleeman, David J. Glass, Evelyn Gasparino, Jesus Trejos, John D. Davis, Boaz Hirshberg, Robert Pordy, George D. Yancopoulos, Gary A. Herman

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: